EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.17.3 | Adenocarcinoma |
3038783 |
Kininase I, kininase II and aminopeptidase levels in patients with gastrointestinal tumors. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 3.4.17.3 | Alzheimer Disease |
18712120 |
[Activity of peptidyl-dipeptidase A and carboxypeptidase N in the serum of patients with Alzheimer disease] |
diagnostic usage
unassigned |
4
0 |
| 3.4.17.3 | Anaphylaxis |
3028062 |
Aggregate anaphylaxis and carboxypeptidase N. |
unassigned |
0 |
| 3.4.17.3 | Anaphylaxis |
3943918 |
Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
1
1
1 |
| 3.4.17.3 | Angina, Unstable |
3681119 |
Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N. |
causal interaction
diagnostic usage
unassigned |
2
3
0 |
| 3.4.17.3 | Angioedema |
6762276 |
The role of complement in urticaria and angioedema. |
therapeutic application
unassigned |
3
0 |
| 3.4.17.3 | Angioedema |
7437116 |
Familial carboxypeptidase N deficiency. |
diagnostic usage
unassigned |
3
0 |
| 3.4.17.3 | Angioedema |
9267242 |
Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
4
0 |
| 3.4.17.3 | Arthritis |
3041137 |
Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.4.17.3 | Arthritis, Gouty |
24974054 |
Tissue factor pathway inhibitor and thrombin-activatable carboxypeptidase B for prediction of early atherosclerosis in gouty arthritis. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
